Mimi Lin, MD
Gastroenterology · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Hospitals listed: California Pacific Medical Center- Van Ness Campus · California Pacific Medical Ctr-Davies Campus Hosp. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Lin’s office to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- California Pacific Medical Ctr-Davies Campus HospSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · No emergency departmentPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.187, Oct 2024 – Sep 2025
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for California Pacific Medical Ctr-Davies Campus Hosp
Behind the star rating — Deaths: 0 better, 4 the same, 0 worse of 4 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 0 better, 4 the same, 1 worse of 5 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.187 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.02 (0 to 2.09) · 232 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.98 (0.56 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for heart failure patientsComplications and deaths | 10 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.1 · 106 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 721 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.49) · 2,031 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.25 (0.04 to 0.45) · 2,032 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.35 (0.94 to 5.76) · 419 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.41 (0 to 3) · 211 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.84 (1.24 to 4.44) · 414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.95 (2.91 to 20.98) · 218 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.61 (1.47 to 9.75) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.74 (0.22 to 3.26) · 52 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 1,461 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.6 · 58 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.756 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 91 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 65.3 · 84 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.6 · 115 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 55 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 25 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 312 cases | No different | Jan 2024 – Dec 2024 |
What patients said (602 patients answered, 22% of those asked)
| Cleanliness | 4 |
| Nurse communication | 2 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 68% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 46% |
| Yes, staff "did" give patients information about possible symptoms | 85% |
Original Medicare doctor bills
$97,373
Medicare paid this office $97,373 for 298 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 49 | $9,441 | $160 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 39 | $8,851 | $227 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 107 | $8,557 | $78 |
| Biopsy of large bowel using a flexible endoscope | 64 | $6,769 | $106 |
| New patient visit (60+ min) | 44 | $6,667 | $152 |
See all 21 services
| Long return visit (40+ min) | 49 | $9,441 | $160 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 39 | $8,851 | $227 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 107 | $8,557 | $78 |
| Biopsy of large bowel using a flexible endoscope | 64 | $6,769 | $106 |
| New patient visit (60+ min) | 44 | $6,667 | $152 |
| Return visit (30+ min) | 39 | $5,159 | $112 |
| New patient visit (60+ min) | 24 | $4,534 | $189 |
| Control of bleeding of small bowel using an endoscope | 13 | $4,399 | $338 |
| Study of esophagus to assess movement | 62 | $3,640 | $56 |
| New patient visit (45+ min) | 26 | $2,958 | $114 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 62 | $2,867 | $43 |
| Study of rectum sensitivity and function | 35 | $2,729 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 15 | $2,311 | $154 |
| Dilation of stomach outlet using a flexible endoscope | 15 | $2,059 | $137 |
| Ultrasound exam of lower large bowel using a flexible endoscope | 17 | $1,890 | $111 |
| Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 27 | $1,842 | $59 |
| Study of esophageal sensation by balloon distension | 38 | $1,662 | $44 |
| Test for tone and sensation of rectum and anus | 35 | $1,503 | $43 |
| Long return visit (40+ min) | 11 | $1,422 | $129 |
| Monitoring and recording of esophageal function through a capsule attached to the esophagus wall | 14 | $1,006 | $72 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 31 | $521 | $15 |
Procedures Medicare counted
| Colonoscopy | 70 | More than 71% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 202 | More than 90% of doctors who do this |
Who their Medicare patients are
298 Original Medicare patients in 2024. Average age 71 · Under 65 15% · 85 and older 7% · Women 65% · Also on Medicaid 28% · Health risk score 1.45. Above the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 64% · Depression 31% · Diabetes 27% · Coronary heart disease 27% · Chronic kidney disease 26% · Cancer 17% · COPD 16% · Heart failure 15% · Atrial fibrillation 14% · Stroke 7%.
The office billed $997,934, Medicare allowed $123,011 and paid $97,373; for 972 services of 54 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 298 | 972 | 71 | 1.45 | $997,934 | $97,373 |
| 2023 | 362 | 986 | 70 | 1.53 | $913,470 | $103,412 |
| 2022 | 347 | 962 | 70 | 1.48 | $902,905 | $98,528 |
| 2021 | 367 | 1,175 | 69 | 1.78 | $938,891 | $115,135 |
| 2020 | 369 | 1,099 | 68 | 1.89 | $891,539 | $109,579 |
| 2019 | 365 | 961 | 69 | 1.89 | $773,822 | $95,842 |
| 2018 | 335 | 1,030 | 69 | 1.98 | $717,804 | $96,462 |
| 2017 | 323 | 989 | 67 | 2.08 | $720,459 | $90,858 |
| 2016 | 272 | 947 | 68 | 1.78 | $697,637 | $96,012 |
| 2015 | 247 | 1,006 | 68 | 2.28 | $727,227 | $114,820 |
| 2014 | 215 | 751 | 68 | 1.94 | $480,068 | $75,505 |
| 2013 | 249 | 810 | 67 | 2.16 | $498,827 | $78,536 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 21 services
| Long return visit (40+ min) | 71 | $11,940 | $149 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 92 | $8,337 | $87 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 33 | $7,601 | $224 |
| Biopsy of large bowel using a flexible endoscope | 61 | $6,807 | $112 |
| New patient visit (60+ min) | 30 | $5,790 | $193 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,309 | $156 |
| Return visit (30+ min) | 53 | $5,304 | $98 |
| New patient visit (60+ min) | 32 | $4,827 | $151 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $3,744 | $71 |
| Study of rectum sensitivity and function | 37 | $2,953 | $80 |
| Study of esophagus to assess movement | 48 | $2,857 | $58 |
| New patient visit (45+ min) | 19 | $2,820 | $148 |
| New patient visit (45+ min) | 22 | $2,416 | $110 |
| Dilation of stomach outlet using a flexible endoscope | 14 | $2,399 | $150 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 47 | $2,122 | $44 |
| Ultrasound exam of lower large bowel using a flexible endoscope | 17 | $1,852 | $109 |
| Test for tone and sensation of rectum and anus | 37 | $1,627 | $44 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,295 | $108 |
| Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 22 | $991 | $35 |
| Study of esophageal sensation by balloon distension | 22 | $957 | $44 |
| Monitoring and recording of esophageal function through a capsule attached to the esophagus wall | 12 | $828 | $69 |
2022: 18 services
| Long return visit (40+ min) | 76 | $12,619 | $148 |
| New patient visit (60+ min) | 44 | $8,606 | $196 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 101 | $7,766 | $71 |
| Biopsy of large bowel using a flexible endoscope | 63 | $7,734 | $121 |
| Return visit (30+ min) | 69 | $7,696 | $104 |
| Dilation of stomach outlet using a flexible endoscope | 26 | $4,177 | $144 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 20 | $3,974 | $199 |
| New patient visit (60+ min) | 24 | $3,957 | $165 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $3,375 | $178 |
| Study of esophagus to assess movement | 57 | $3,265 | $56 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $3,140 | $64 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 56 | $2,580 | $45 |
| New patient visit (45+ min) | 18 | $2,239 | $124 |
| Study of rectum sensitivity and function | 28 | $2,229 | $80 |
| New patient visit (45+ min) | 18 | $2,079 | $115 |
| Test for tone and sensation of rectum and anus | 28 | $1,239 | $44 |
| Study of esophageal sensation by balloon distension | 23 | $1,033 | $45 |
| Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 32 | $899 | $22 |
2021: 24 services
| Long return visit (40+ min) | 77 | $11,416 | $119 |
| Long return visit (40+ min) | 58 | $10,884 | $149 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 107 | $7,246 | $62 |
| New patient visit (60+ min) | 46 | $7,138 | $155 |
| Biopsy of large bowel using a flexible endoscope | 51 | $7,031 | $138 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,943 | $180 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 23 | $5,176 | $225 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 31 | $5,001 | $65 |
| New patient visit (60+ min) | 27 | $4,627 | $171 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $4,576 | $93 |
| Study of esophagus to assess movement | 69 | $4,347 | $60 |
| Insertion of tube or tube in esophagus, stomach, and/or upper small bowel using a flexible endoscope | 39 | $4,304 | $105 |
| Return visit (30+ min) | 31 | $3,646 | $114 |
| New patient visit (45+ min) | 26 | $2,802 | $108 |
| Study of rectum sensitivity and function | 33 | $2,550 | $77 |
| Monitoring and recording of esophageal function through nasal tube with electrode | 51 | $2,380 | $46 |
| Return visit (30+ min) | 26 | $1,910 | $73 |
| Imaging of digestive tract done from the inside of the digestive tract | 15 | $1,772 | $118 |
| Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 24 | $1,747 | $60 |
| New patient visit (45+ min) | 13 | $1,705 | $131 |
| Test for tone and sensation of rectum and anus | 31 | $1,354 | $44 |
| Study of stomach to assess movement | 11 | $753 | $68 |
| Prolonged monitoring and recording of esophageal function through nasal tube with electrode | 11 | $572 | $52 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 12 | $115 | $10 |
2020: 20 services
| Long return visit (40+ min) | 128 | $15,742 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 33 | $11,323 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 43 | $9,062 | $185 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 112 | $7,239 | $62 |
| New patient visit (60+ min) | 51 | $7,050 | $138 |
| Insertion of tube or tube in esophagus, stomach, and/or upper small bowel using a flexible endoscope | 57 | $6,940 | $122 |
| Long return visit (40+ min) | 39 | $6,811 | $129 |
| New patient visit (60+ min) | 33 | $5,474 | $166 |
| Biopsy of large bowel using a flexible endoscope | 39 | $5,192 | $133 |
| Study of esophagus to assess movement | 56 | $3,685 | $61 |
| Imaging of digestive tract done from the inside of the digestive tract | 25 | $3,107 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 25 | $2,718 | $66 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $2,645 | $220 |
| Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 28 | $2,087 | $63 |
| New patient visit (45+ min) | 17 | $1,957 | $115 |
| Study of stomach to assess movement | 25 | $1,745 | $70 |
| Study of rectum sensitivity and function | 23 | $1,725 | $75 |
| Test for tone and sensation of rectum and anus | 23 | $1,020 | $44 |
| Study of esophageal sensation by balloon distension | 13 | $599 | $46 |
| Imaging guidance for procedure, 60 minutes or less | 23 | $321 | $14 |
2019: 20 services
| Long return visit (40+ min) | 102 | $13,161 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 56 | $12,557 | $94 |
| New patient visit (60+ min) | 83 | $11,420 | $138 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,658 | $182 |
| Biopsy of large bowel using a flexible endoscope | 50 | $7,044 | $141 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 79 | $6,256 | $75 |
| Insertion of tube or tube in esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $3,367 | $129 |
| Study of rectum sensitivity and function | 40 | $3,223 | $81 |
| Study of esophagus to assess movement | 42 | $2,512 | $58 |
| Diagnostic exam of large bowel using a flexible endoscope | 14 | $2,280 | $163 |
| Ultrasound exam of lower large bowel using a flexible endoscope | 21 | $2,175 | $104 |
| Test for tone and sensation of rectum and anus | 38 | $1,699 | $45 |
| Study of stomach to assess movement | 23 | $1,664 | $69 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,180 | $66 |
| Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 15 | $1,179 | $65 |
| New patient visit (45+ min) | 11 | $1,159 | $105 |
| Return visit (30+ min) | 15 | $855 | $57 |
| Study of esophageal sensation by balloon distension | 12 | $514 | $43 |
| Imaging guidance for procedure, 60 minutes or less | 18 | $249 | $14 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 17 | $159 | $9 |
2018: 18 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 63 | $15,915 | $90 |
| New patient visit (60+ min) | 103 | $13,476 | $131 |
| Long return visit (40+ min) | 105 | $12,392 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 52 | $9,328 | $170 |
| Insertion of tube or tube in esophagus, stomach, and/or upper small bowel using a flexible endoscope | 34 | $3,587 | $100 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 59 | $3,528 | $60 |
| Biopsy of large bowel using a flexible endoscope | 20 | $2,909 | $145 |
| Study of rectum sensitivity and function | 32 | $2,479 | $77 |
| Study of esophagus to assess movement | 40 | $2,386 | $58 |
| Study of stomach to assess movement | 26 | $1,786 | $66 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,759 | $63 |
| Test for tone and sensation of rectum and anus | 32 | $1,388 | $43 |
| Ultrasound exam of lower large bowel using a flexible endoscope | 14 | $1,387 | $99 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,204 | $93 |
| Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,035 | $54 |
| Study of movement of the upper small bowel (duodenum) | 14 | $928 | $66 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 22 | $196 | $9 |
| Imaging guidance for procedure, 60 minutes or less | 20 | $148 | $7 |
2017: 24 services
| Long return visit (40+ min) | 101 | $11,497 | $89 |
| New patient visit (60+ min) | 79 | $11,001 | $139 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $8,597 | $175 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 43 | $8,373 | $90 |
| Biopsy of large bowel using a flexible endoscope | 37 | $4,985 | $135 |
| Insertion of tube or tube in esophagus, stomach, and/or upper small bowel using a flexible endoscope | 39 | $4,534 | $111 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 58 | $4,193 | $71 |
| Study of stomach to assess movement | 40 | $2,757 | $66 |
| Study of rectum sensitivity and function | 33 | $2,612 | $79 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 12 | $2,483 | $207 |
| Diagnostic exam of large bowel using a flexible endoscope | 15 | $2,389 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $2,006 | $63 |
| Imaging of digestive tract done from the inside of the digestive tract | 12 | $1,681 | $140 |
| New patient visit (45+ min) | 13 | $1,454 | $112 |
| Test for tone and sensation of rectum and anus | 33 | $1,445 | $44 |
| Return visit (30+ min) | 23 | $1,433 | $60 |
| Study of esophagus to assess movement | 24 | $1,415 | $59 |
| Study of movement of the upper small bowel (duodenum) | 20 | $1,335 | $67 |
| Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,154 | $61 |
| Study of esophageal sensation by balloon distension | 14 | $620 | $44 |
| Imaging guidance for procedure, 60 minutes or less | 37 | $280 | $7 |
| Electronic analysis of implanted gastric neurostimulator generator | 11 | $171 | $14 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 28 | $126 | $4 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 14 | $116 | $8 |
2016: 23 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 51 | $12,415 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $12,154 | $176 |
| Long return visit (40+ min) | 81 | $10,326 | $91 |
| New patient visit (60+ min) | 49 | $6,949 | $142 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 46 | $4,104 | $89 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 15 | $3,538 | $236 |
| Biopsy of large bowel using a flexible endoscope | 29 | $3,445 | $119 |
| Insertion of tube or tube in esophagus, stomach, and/or upper small bowel using a flexible endoscope | 23 | $3,097 | $129 |
| Study of esophagus to assess movement | 37 | $2,220 | $60 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $2,156 | $63 |
| Return visit (30+ min) | 30 | $2,065 | $59 |
| Imaging of digestive tract done from the inside of the digestive tract | 12 | $2,054 | $171 |
| Study of rectum sensitivity and function | 23 | $1,834 | $80 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 14 | $1,695 | $106 |
| Study of stomach to assess movement | 24 | $1,692 | $68 |
| New patient visit (45+ min) | 20 | $1,642 | $82 |
| Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 19 | $1,409 | $74 |
| Ultrasound exam of lower large bowel using a flexible endoscope | 12 | $1,243 | $104 |
| Test for tone and sensation of rectum and anus | 23 | $1,025 | $45 |
| Study of esophageal sensation by balloon distension | 13 | $588 | $45 |
| Prolonged monitoring and recording of esophageal function through nasal tube with electrode | 11 | $565 | $51 |
| Imaging guidance for procedure, 60 minutes or less | 27 | $220 | $8 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 20 | $191 | $9 |
2015: 23 services
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $9,292 | $182 |
| Return visit (30+ min) | 57 | $7,151 | $93 |
| New patient visit (60+ min) | 35 | $6,513 | $186 |
| Long return visit (40+ min) | 43 | $6,411 | $126 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 26 | $6,289 | $94 |
| Control of bleeding of small bowel using an endoscope | 16 | $6,208 | $365 |
| Biopsy of large bowel using a flexible endoscope | 22 | $3,765 | $171 |
| Insertion of tube or tube in esophagus, stomach, and/or upper small bowel using a flexible endoscope | 28 | $3,684 | $132 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 46 | $3,281 | $64 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $3,256 | $65 |
| Imaging of digestive tract done from the inside of the digestive tract | 17 | $3,013 | $177 |
| New patient visit (45+ min) | 18 | $2,539 | $141 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 25 | $2,235 | $35 |
| Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 26 | $2,083 | $80 |
| Study of stomach to assess movement | 29 | $2,021 | $70 |
| Return visit (30+ min) | 27 | $1,981 | $71 |
| New patient visit (60+ min) | 13 | $1,967 | $151 |
| Study of esophagus to assess movement | 30 | $1,955 | $61 |
| Study of rectum sensitivity and function | 23 | $1,875 | $82 |
| Test for tone and sensation of rectum and anus | 23 | $1,062 | $46 |
| Study of movement of the upper small bowel (duodenum) | 12 | $911 | $70 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 25 | $242 | $10 |
| Imaging guidance for procedure, 60 minutes or less | 29 | $225 | $8 |
2014: 19 services
| Return visit (30+ min) | 59 | $7,474 | $100 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,865 | $181 |
| New patient visit (60+ min) | 36 | $6,841 | $190 |
| New patient visit (45+ min) | 33 | $5,028 | $152 |
| Long return visit (40+ min) | 25 | $4,038 | $135 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $3,280 | $64 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 39 | $2,997 | $71 |
| Insertion of tube or tube in esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $2,639 | $139 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 29 | $2,578 | $35 |
| Biopsy of large bowel using a flexible endoscope | 16 | $2,337 | $146 |
| Study of rectum sensitivity and function | 28 | $2,271 | $81 |
| Ultrasound exam of lower large bowel using a flexible endoscope | 11 | $1,559 | $142 |
| Test for tone and sensation of rectum and anus | 28 | $1,284 | $46 |
| Study of esophagus to assess movement | 20 | $1,240 | $62 |
| Study of stomach to assess movement | 16 | $1,057 | $66 |
| Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $854 | $66 |
| Study of movement of the upper small bowel (duodenum) | 12 | $836 | $70 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 26 | $251 | $10 |
| Imaging guidance for procedure, 60 minutes or less | 24 | $197 | $8 |
2013: 21 services
| New patient visit (60+ min) | 46 | $8,284 | $180 |
| Return visit (30+ min) | 61 | $6,728 | $93 |
| Long return visit (40+ min) | 39 | $6,548 | $134 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 45 | $5,894 | $128 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 26 | $5,099 | $176 |
| Biopsy of large bowel using a flexible endoscope | 19 | $3,905 | $206 |
| New patient visit (45+ min) | 23 | $3,385 | $147 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 29 | $3,199 | $63 |
| Study of esophagus to assess movement | 39 | $2,330 | $60 |
| Study of rectum sensitivity and function | 28 | $2,212 | $79 |
| Injection of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $2,025 | $145 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 13 | $1,980 | $132 |
| Test for tone and sensation of rectum and anus | 30 | $1,343 | $45 |
| Study of stomach to assess movement | 16 | $1,329 | $70 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 30 | $1,324 | $34 |
| Biofeedback training, perineal muscles, anorectal or urethral sphincter | 11 | $1,117 | $39 |
| Prolonged monitoring and recording of esophageal function through nasal tube with electrode | 11 | $578 | $53 |
| Insertion of tube or tube in esophagus, stomach, and/or upper small bowel using a flexible endoscope | 11 | $495 | $45 |
| Measurement of hydrogen in breath to test for stomach and bowel symptoms | 41 | $409 | $10 |
| Review by radiologist of placement of long small bowel tube | 15 | $355 | $24 |
| Imaging guidance for procedure, 60 minutes or less | 13 | $106 | $8 |
Medicaid work
$2,807 in 2023
Medicaid paid $2,807 for 26 billed services this clinician did in 2023, up to 14 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Upper gastrointestinal endoscopy with biopsy | 14 | $2,057 |
| Long return visit (40+ min) | 12 | $750 |
| 2023 | 26 | 2 | 14 | $2,807 |
| 2021 | 40 | 2 | 15 | $3,953 |
| 2020 | 64 | 2 | 20 | $4,153 |
| 2019 | 12 | 1 | 12 | $484 |
See the largest Medicaid services in earlier years
2021
| Upper gastrointestinal endoscopy with biopsy | 13 | $2,354 |
| Long return visit (40+ min) | 27 | $1,600 |
2020
| Upper gastrointestinal endoscopy with biopsy | 16 | $2,274 |
| Long return visit (40+ min) | 48 | $1,879 |
2019
| Long return visit (40+ min) | 12 | $484 |
Drugs they prescribed that Part D paid
$199,452
Pharmacies billed $199,452 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 631) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
428 generic and 203 brand-name prescriptions · $199,452 in drug cost · 26 antibiotic prescriptions to 13 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Linzess | 48 | $53,047 | $1,105 |
| Motegrity | 24 | $25,816 | $1,076 |
| Erythromycin | 18 | $8,594 | $477 |
| Sod Sulf-Potass Sulf-Mag Sulf | 115 | $7,539 | $66 |
| Dexlansoprazole Dr | 11 | $4,955 | $450 |
See all 17 drugs
| Linzess | 48 | $53,047 | $1,105 |
| Motegrity | 24 | $25,816 | $1,076 |
| Erythromycin | 18 | $8,594 | $477 |
| Sod Sulf-Potass Sulf-Mag Sulf | 115 | $7,539 | $66 |
| Dexlansoprazole Dr | 11 | $4,955 | $450 |
| Sucralfate | 23 | $4,362 | $190 |
| Movantik | 11 | $3,938 | $358 |
| Pyridostigmine | 25 | $2,196 | $88 |
| Scopolamine | 14 | $1,430 | $102 |
| Pantoprazole | 47 | $1,214 | $26 |
| Ondansetron Odt | 28 | $991 | $35 |
| Omeprazole | 68 | $977 | $14 |
| Mirtazapine | 20 | $839 | $42 |
| Esomeprazole Magnesium | 13 | $491 | $38 |
| Promethazine | 11 | $337 | $31 |
| Metoclopramide | 31 | $324 | $10 |
| Lansoprazole | 12 | $300 | $25 |
Year by year
| 2024 | 631 | 230 | 0% (0) | 32% | $199,452 |
| 2023 | 838 | 257 | 0% (0) | None | $351,464 |
| 2022 | 969 | 236 | 0% (0) | None | $663,329 |
| 2021 | 1,191 | 292 | 0% (0) | 37% | $938,401 |
| 2020 | 1,302 | 305 | 0% (0) | None | $738,116 |
| 2019 | 919 | 242 | None | None | $285,808 |
| 2018 | 897 | 207 | 0% (0) | None | $241,899 |
| 2017 | 979 | 221 | None | None | $267,130 |
| 2016 | 973 | 190 | None | 33% | $210,583 |
| 2015 | 783 | 150 | None | None | $123,462 |
| 2014 | 511 | 112 | None | None | $63,941 |
| 2013 | 474 | 105 | None | None | $62,020 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 23 drugs
| Linzess | 70 | $84,305 | $1,204 |
| Motegrity | 37 | $39,207 | $1,060 |
| Creon | 11 | $32,954 | $2,996 |
| Xifaxan | 11 | $26,422 | $2,402 |
| Erythromycin | 31 | $19,462 | $628 |
| Dexlansoprazole Dr | 19 | $9,040 | $476 |
| Sucralfate | 30 | $7,965 | $265 |
| Sod Sulf-Potass Sulf-Mag Sulf | 88 | $6,797 | $77 |
| Lubiprostone | 12 | $6,618 | $552 |
| Pyridostigmine | 33 | $2,298 | $70 |
| Omeprazole | 62 | $1,563 | $25 |
| Pantoprazole | 56 | $1,478 | $26 |
| Esomeprazole Magnesium | 18 | $1,270 | $71 |
| Mirtazapine | 24 | $1,250 | $52 |
| Ondansetron Odt | 28 | $1,073 | $38 |
| Promethazine | 18 | $709 | $39 |
| Amitriptyline | 18 | $414 | $23 |
| Metoclopramide | 21 | $306 | $15 |
| Buspirone | 17 | $280 | $16 |
| Famotidine | 13 | $256 | $20 |
| Gavilyte-C | 13 | $231 | $18 |
| Ondansetron | 12 | $150 | $13 |
| Lactulose | 11 | $19 | $2 |
2022: 29 drugs
| Creon | 36 | $135,570 | $3,766 |
| Linzess | 79 | $91,525 | $1,159 |
| Xifaxan | 16 | $59,146 | $3,697 |
| Sancuso | 13 | $35,325 | $2,717 |
| Motegrity | 35 | $33,343 | $953 |
| Erythromycin | 36 | $26,491 | $736 |
| Dexilant | 24 | $17,820 | $743 |
| Sucralfate | 47 | $13,471 | $287 |
| Dexlansoprazole Dr | 13 | $7,298 | $561 |
| Lubiprostone | 14 | $7,021 | $501 |
| Suprep | 57 | $6,595 | $116 |
| Esomeprazole Magnesium | 14 | $4,031 | $288 |
| Pyridostigmine | 34 | $2,562 | $75 |
| Pantoprazole | 78 | $2,013 | $26 |
| Sod Sulf-Potass Sulf-Mag Sulf | 21 | $1,673 | $80 |
| Omeprazole | 72 | $1,490 | $21 |
| Ondansetron Odt | 22 | $1,174 | $53 |
| Buspirone | 35 | $912 | $26 |
| Mirtazapine | 25 | $775 | $31 |
| Promethazine | 23 | $706 | $31 |
| Gabapentin | 12 | $630 | $52 |
| Amitriptyline | 20 | $618 | $31 |
| Nortriptyline | 11 | $609 | $55 |
| Dicyclomine | 17 | $609 | $36 |
| Prochlorperazine Maleate | 14 | $503 | $36 |
| Ondansetron | 13 | $460 | $35 |
| Metoclopramide | 17 | $412 | $24 |
| Diltiazem 24hr Er (Cd) | 12 | $339 | $28 |
| Famotidine | 15 | $314 | $21 |
2021: 29 drugs
| Linzess | 120 | $130,267 | $1,086 |
| Xifaxan | 28 | $78,343 | $2,798 |
| Creon | 26 | $77,497 | $2,981 |
| Sancuso | 15 | $38,591 | $2,573 |
| Motegrity | 28 | $33,170 | $1,185 |
| Dexilant | 39 | $28,437 | $729 |
| Erythromycin | 46 | $27,302 | $594 |
| Sucralfate | 67 | $23,190 | $346 |
| Aprepitant | 12 | $20,040 | $1,670 |
| Suprep | 89 | $9,932 | $112 |
| Amitiza | 16 | $9,707 | $607 |
| Sumatriptan | 16 | $3,755 | $235 |
| Esomeprazole Magnesium | 13 | $3,231 | $249 |
| Pyridostigmine | 38 | $2,648 | $70 |
| Pantoprazole | 93 | $2,279 | $25 |
| Ondansetron Odt | 36 | $2,175 | $60 |
| Bethanechol Chloride | 25 | $2,026 | $81 |
| Omeprazole | 44 | $1,049 | $24 |
| Ondansetron | 23 | $1,047 | $46 |
| Diltiazem 24hr Er (Cd) | 24 | $911 | $38 |
| Famotidine | 26 | $891 | $34 |
| Promethazine | 38 | $878 | $23 |
| Amitriptyline | 32 | $783 | $24 |
| Gabapentin | 12 | $735 | $61 |
| Mirtazapine | 23 | $702 | $31 |
| Buspirone | 51 | $578 | $11 |
| Nortriptyline | 14 | $490 | $35 |
| Prochlorperazine Maleate | 16 | $462 | $29 |
| Metoclopramide | 22 | $345 | $16 |
2020: 29 drugs
| Linzess | 131 | $117,689 | $898 |
| Xifaxan | 33 | $87,208 | $2,643 |
| Creon | 29 | $61,132 | $2,108 |
| Motegrity | 36 | $31,228 | $867 |
| Dexilant | 68 | $31,189 | $459 |
| Amitiza | 39 | $29,518 | $757 |
| Erythromycin | 28 | $21,925 | $783 |
| Carafate | 11 | $15,028 | $1,366 |
| Sucralfate | 75 | $11,959 | $159 |
| Suprep | 63 | $6,770 | $107 |
| Scopolamine | 27 | $4,170 | $154 |
| Pyridostigmine | 40 | $3,109 | $78 |
| Octreotide Acetate | 19 | $2,603 | $137 |
| Ondansetron Odt | 42 | $2,318 | $55 |
| Pantoprazole | 104 | $2,284 | $22 |
| Bethanechol Chloride | 16 | $1,399 | $87 |
| Ondansetron | 22 | $1,157 | $53 |
| Amitriptyline | 38 | $1,055 | $28 |
| Omeprazole | 54 | $917 | $17 |
| Promethazine | 40 | $793 | $20 |
| Gabapentin | 14 | $770 | $55 |
| Nortriptyline | 25 | $768 | $31 |
| Diphenoxylate-Atropine | 12 | $742 | $62 |
| Famotidine | 18 | $661 | $37 |
| Dicyclomine | 23 | $538 | $23 |
| Mirtazapine | 29 | $533 | $18 |
| Metoclopramide | 37 | $520 | $14 |
| Pregabalin | 13 | $517 | $40 |
| Buspirone | 27 | $435 | $16 |
2019: 25 drugs
| Linzess | 94 | $63,093 | $671 |
| Xifaxan | 14 | $42,640 | $3,046 |
| Amitiza | 52 | $37,430 | $720 |
| Relistor | 15 | $26,586 | $1,772 |
| Creon | 12 | $19,005 | $1,584 |
| Erythromycin | 21 | $15,072 | $718 |
| Dexilant | 30 | $14,102 | $470 |
| Motegrity | 16 | $7,980 | $499 |
| Suprep | 75 | $7,484 | $100 |
| Flovent Hfa | 12 | $4,731 | $394 |
| Movantik | 11 | $4,083 | $371 |
| Octreotide Acetate | 25 | $3,051 | $122 |
| Pyridostigmine | 31 | $2,433 | $78 |
| Sucralfate | 37 | $2,068 | $56 |
| Pantoprazole | 67 | $1,079 | $16 |
| Gabapentin | 40 | $919 | $23 |
| Omeprazole | 55 | $884 | $16 |
| Amitriptyline | 12 | $629 | $52 |
| Metoclopramide | 35 | $443 | $13 |
| Dicyclomine | 20 | $333 | $17 |
| Ondansetron | 13 | $323 | $25 |
| Buspirone | 27 | $296 | $11 |
| Mirtazapine | 15 | $192 | $13 |
| Promethazine | 14 | $148 | $11 |
| Lorazepam | 13 | $56 | $4 |
2018: 20 drugs
| Xifaxan | 18 | $51,911 | $2,884 |
| Linzess | 87 | $46,255 | $532 |
| Amitiza | 37 | $21,073 | $570 |
| Erythromycin | 27 | $19,294 | $715 |
| Dexilant | 31 | $19,234 | $620 |
| Carafate | 15 | $6,777 | $452 |
| Trulance | 11 | $4,325 | $393 |
| Suprep | 44 | $4,160 | $95 |
| Pyridostigmine | 43 | $3,022 | $70 |
| Sucralfate | 30 | $1,111 | $37 |
| Omeprazole | 69 | $1,044 | $15 |
| Pantoprazole | 51 | $787 | $15 |
| Gabapentin | 44 | $713 | $16 |
| Amitriptyline | 16 | $534 | $33 |
| Metoclopramide | 54 | $532 | $10 |
| Buspirone | 35 | $506 | $14 |
| Nortriptyline | 16 | $353 | $22 |
| Dicyclomine | 24 | $305 | $13 |
| Lorazepam | 16 | $51 | $3 |
| Ranitidine | 12 | $42 | $3 |
2017: 24 drugs
| Xifaxan | 23 | $72,063 | $3,133 |
| Linzess | 102 | $46,420 | $455 |
| Dexilant | 44 | $18,178 | $413 |
| Amitiza | 40 | $17,509 | $438 |
| Erythromycin | 18 | $15,713 | $873 |
| Carafate | 14 | $6,120 | $437 |
| Suprep | 40 | $3,505 | $88 |
| Pyridostigmine | 30 | $1,782 | $59 |
| Ondansetron | 33 | $988 | $30 |
| Gabapentin | 37 | $917 | $25 |
| Amitriptyline | 32 | $841 | $26 |
| Sucralfate | 21 | $821 | $39 |
| Ondansetron Odt | 22 | $804 | $37 |
| Buspirone | 31 | $655 | $21 |
| Nitroglycerin | 12 | $621 | $52 |
| Omeprazole | 62 | $598 | $10 |
| Pantoprazole | 46 | $568 | $12 |
| Nortriptyline | 28 | $451 | $16 |
| Metoclopramide | 53 | $375 | $7 |
| Dicyclomine | 27 | $300 | $11 |
| Famotidine | 22 | $289 | $13 |
| Gavilyte-G | 23 | $288 | $13 |
| Mirtazapine | 11 | $105 | $10 |
| Lorazepam | 13 | $39 | $3 |
2016: 25 drugs
| Xifaxan | 28 | $54,018 | $1,929 |
| Linzess | 103 | $32,528 | $316 |
| Amitiza | 47 | $20,832 | $443 |
| Zenpep | 12 | $11,466 | $955 |
| Dexilant | 35 | $8,745 | $250 |
| Esomeprazole Magnesium | 13 | $3,855 | $297 |
| Octreotide Acetate | 11 | $2,930 | $266 |
| Suprep | 26 | $2,149 | $83 |
| Amitriptyline | 42 | $867 | $21 |
| Dicyclomine | 46 | $755 | $16 |
| Gabapentin | 41 | $750 | $18 |
| Pyridostigmine | 20 | $715 | $36 |
| Ondansetron | 18 | $649 | $36 |
| Nortriptyline | 48 | $631 | $13 |
| Pantoprazole | 39 | $582 | $15 |
| Metoclopramide | 59 | $520 | $9 |
| Buspirone | 37 | $366 | $10 |
| Omeprazole | 42 | $307 | $7 |
| Metronidazole | 20 | $237 | $12 |
| Polyethylene Glycol 3350 | 15 | $226 | $15 |
| Gavilyte-G | 12 | $155 | $13 |
| Mirtazapine | 14 | $154 | $11 |
| Famotidine | 21 | $145 | $7 |
| Lorazepam | 30 | $144 | $5 |
| Ciprofloxacin | 11 | $67 | $6 |
2015: 21 drugs
| Linzess | 81 | $23,126 | $286 |
| Xifaxan | 18 | $22,873 | $1,271 |
| Amitiza | 30 | $9,549 | $318 |
| Zenpep | 13 | $8,725 | $671 |
| Dexilant | 26 | $7,372 | $284 |
| Fulyzaq | 11 | $5,850 | $532 |
| Suprep | 22 | $1,807 | $82 |
| Metoclopramide | 71 | $909 | $13 |
| Amitriptyline | 58 | $891 | $15 |
| Sucralfate | 12 | $803 | $67 |
| Ondansetron | 14 | $728 | $52 |
| Buspirone | 40 | $487 | $12 |
| Dicyclomine | 35 | $413 | $12 |
| Pantoprazole | 27 | $365 | $14 |
| Nortriptyline | 34 | $323 | $10 |
| Polyethylene Glycol 3350 | 15 | $285 | $19 |
| Metronidazole | 21 | $274 | $13 |
| Omeprazole | 25 | $241 | $10 |
| Ranitidine | 23 | $188 | $8 |
| Lorazepam | 23 | $124 | $5 |
| Ciprofloxacin | 16 | $68 | $4 |
2014: 10 drugs
| Amitiza | 38 | $10,093 | $266 |
| Dexilant | 37 | $9,582 | $259 |
| Linzess | 32 | $9,271 | $290 |
| Metoclopramide | 46 | $438 | $10 |
| Polyethylene Glycol 3350 | 16 | $326 | $20 |
| Dicyclomine | 17 | $273 | $16 |
| Nortriptyline | 37 | $236 | $6 |
| Pantoprazole | 15 | $175 | $12 |
| Buspirone | 11 | $164 | $15 |
| Amitriptyline | 28 | $158 | $6 |
2013: 16 drugs
| Nexium | 29 | $11,536 | $398 |
| Amitiza | 28 | $9,572 | $342 |
| Octreotide Acetate | 15 | $5,912 | $394 |
| Dexilant | 26 | $4,805 | $185 |
| Erythromycin | 12 | $3,040 | $253 |
| Carafate | 11 | $2,973 | $270 |
| Moviprep | 22 | $1,553 | $71 |
| Nitrostat | 21 | $1,120 | $53 |
| Ondansetron Odt | 12 | $1,003 | $84 |
| Ondansetron | 20 | $911 | $46 |
| Nortriptyline | 31 | $456 | $15 |
| Buspirone | 12 | $414 | $35 |
| Metoclopramide | 45 | $386 | $9 |
| Dicyclomine | 17 | $286 | $17 |
| Omeprazole | 17 | $170 | $10 |
| Pantoprazole | 17 | $132 | $8 |
Money from drug and device companies
$3,943 in 2025
| 2025 | 8 | 15 | $3,491 | $3,943 |
| 2024 | 11 | 26 | $2,475 | $3,569 |
| 2023 | 6 | 17 | None | $376 |
| 2022 | 7 | 10 | $17,186 | $18,886 |
| 2021 | 3 | 8 | $11,145 | $11,145 |
| 2020 | 8 | 20 | $8,000 | $8,253 |
| 2019 | 12 | 77 | $13,100 | $15,079 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Olympus Medical Systems | Evis Exera II Small Intestinal Videoscope | $3,491 | 1 payment
|
| Abbvie | Skyrizi | $137 | 5 payments
|
| Intuitive Surgical | Da Vinci Surgical System | $130 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $69 | 3 payments
|
| Celltrion USA | Vegzelma | $43 | 2 payments
|
| Lilly USA | Omvoh | $34 | 1 payment
|
See all 15 published payments
| Abbvie | Meals · 2025-12-16 | Skyrizi | $27 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-12-03 | Entyvio | $27 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-12-02 | Entyvio | $16 |
| Novo Nordisk | Meals · 2025-11-04 | Wegovy | $18 |
| Intuitive Surgical | Meals · 2025-09-16 | Da Vinci Surgical System | $130 |
| Celltrion USA | Meals · 2025-09-16 | Vegzelma | $21 |
| Abbvie | Meals · 2025-07-17 | Viberzi | $26 |
| Olympus Medical Systems | Consulting · 2025-06-27 | Evis Exera II Small Intestinal Videoscope | $3,491 |
| Lilly USA | Meals · 2025-04-21 | Omvoh | $34 |
| Abbvie | Meals · 2025-04-08 | Skyrizi | $31 |
| Abbvie | Meals · 2025-03-11 | Skyrizi | $29 |
| Abbvie | Meals · 2025-02-25 | Linzess | $24 |
| Takeda Pharmaceuticals U.S.A. | Meals · 2025-02-25 | Entyvio | $26 |
| Celltrion USA | Meals · 2025-02-04 | Vegzelma | $22 |
| Braintree Laboratories | Meals · 2025-01-28 | Suflave | $23 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $3,569
| Medtronic | Endoflip | $3,009 | 8 payments
|
| Enterra Medical | None | $137 | 1 payment
|
| Janssen Biotech | Tremfya | $92 | 3 payments
|
| Abbvie | Linzess | $71 | 3 payments
|
| Celltrion USA | Vegzelma | $66 | 3 payments
|
| Pfizer | Xeljanz | $60 | 3 payments
|
| Olympus America | Endoclot Phs | $40 | 1 payment
|
| Lilly USA | Omvoh | $31 | 1 payment
|
| QOL Medical | Sucraid | $22 | 1 payment
|
| Gilead Sciences | None | $22 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $19 | 1 payment
|
2023: $376
| Takeda Pharmaceuticals U.S.A. | Entyvio | $106 | 6 payments
|
| QOL Medical | Sucraid | $82 | 4 payments
|
| Genzyme | Dupixent | $73 | 3 payments
|
| Janssen Biotech | Stelara | $47 | 2 payments
|
| Myriad Genetic Laboratories | Precisetumor | $43 | 1 payment
|
| Pfizer | Xeljanz | $26 | 1 payment
|
2022: $18,886
| Evoke Pharma | Gimoti | $16,606 | 4 payments
|
| Ardelyx | Ibsrela | $1,500 | 1 payment
|
| Olympus | None | $630 | 1 payment
|
| Enterra Medical | None | $91 | 1 payment
|
| Abbvie | Humira | $27 | 1 payment
|
| QOL Medical | Sucraid | $19 | 1 payment
|
| Celgene | Zeposia | $13 | 1 payment
|
2021: $11,145
| AbbVie | Linzess | $9,225 | 6 payments
|
| Nestle HealthCare Nutrition | Zenpep | $1,500 | 1 payment
|
| Olympus | None | $420 | 1 payment
|
2020: $8,253
| Nestle HealthCare Nutrition | Zenpep | $4,500 | 3 payments
|
| Allergan | Zenpep | $3,571 | 8 payments
|
| AbbVie | Creon | $90 | 4 payments
|
| Gilead Sciences | None | $27 | 1 payment
|
| Pfizer | Xeljanz | $18 | 1 payment
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $18 | 1 payment
|
| Hologic | Brevera | $17 | 1 payment
|
| Ferring Pharmaceuticals | Clenpiq | $14 | 1 payment
|
2019: $15,079
| Allergan | Viberzi | $14,295 | 39 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $202 | 12 payments
|
| Ironwood Pharmaceuticals | Linzess | $199 | 8 payments
|
| AbbVie | Creon | $161 | 6 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $52 | 3 payments
|
| Ferring Pharmaceuticals | Clenpiq | $42 | 2 payments
|
| Braintree Laboratories | Suprep Bowel Prep | $40 | 2 payments
|
| Shire North American Group | Gattex | $21 | 1 payment
|
| Intercept Pharmaceuticals | Ocaliva | $19 | 1 payment
|
| Janssen Biotech | Stelara | $19 | 1 payment
|
| Pfizer | Xeljanz | $15 | 1 payment
|
| Medtronic USA | Enterra | $14 | 1 payment
|
Professional record
- NPI
- 1659588457
- Licence
- CA 810040
- Trained
- Albert Einstein College of Medicine of Yeshiva University, 2002
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 325 Distel Cir, Los Altos, CA, 94022
- NPI first listed
- 2007-05-17
- NPI last updated
- 2025-11-10
- NPI record certified
- 2025-11-10
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 900 Welch Rd, Palo Alto, CA, 94304 · 899 Valencia St, San Francisco, CA, 94110